|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| G01N 33/53 | (2006.01) |
| (11) | Number of the document | 2850101 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13725298.7 |
| Date of filing the European patent application | 2013-05-13 | |
| (97) | Date of publication of the European application | 2015-03-25 |
| (45) | Date of publication and mention of the grant of the patent | 2019-05-01 |
| (46) | Date of publication of the claims translation | 2019-08-12 |
| (86) | Number | PCT/EP2013/059802 |
| Date | 2013-05-13 |
| (87) | Number | WO 2014/019727 |
| Date | 2014-02-06 |
| (30) | Number | Date | Country code |
| 201208370 | 2012-05-14 | GB |
| (72) |
FINNEY, Helene Margaret, GB
LAWSON, Alastair David Griffiths, GB
SHAW, Stevan Graham, GB
SMITH, Bryan John, GB
TYSON, Kerry Louise, GB
KEVORKIAN, Lara, GB
MEIER, Christoph, GB
ATHERFOLD, Paul, Alan, GB
SARKAR, Kaushik, GB
|
| (73) |
UCB Biopharma SRL,
Allée de la Recherche 60, 1070 Brussels,
BE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Anti-FcRn antikūnai |
| ANTI-FCRN ANTIBODIES |
| Payment date | Validity (years) | Amount | |
| 2025-04-02 | 13 | 289.00 EUR |
| 2026-05-13 |